BioPharmSignal logoBioPharmSignal

Biotech News

X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026

X4 Pharmaceuticals (XFOR)X4 PharmaceuticalsCompany update

X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will participate in several upcoming investment conferences in November 2026:

Related news

XFORX4 Pharmaceuticals2026-09-09 11:00 EST

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

XFORX4 Pharmaceuticals2026-10-09 11:00 EST

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

ENTAEnanta Pharmaceuticals2026-11-04 12:00 EST

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

ENTAEnanta Pharmaceuticals2026-09-01 11:00 EST

Enanta Pharmaceuticals to Participate in September Investor Conferences

CABACabaletta Bio2026-11-03 13:00 EST

Cabaletta Bio to Participate in Upcoming Investor Conferences

AVTXAvalo Therapeutics2026-11-02 21:00 EST

Avalo Therapeutics to Participate in Upcoming Investor Conferences

XGNExagen2026-10-29 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conferences

ALECAlector2026-09-03 20:05 EST

Alector to Participate in Upcoming Healthcare Conferences

GPCRStructure Therapeutics2026-09-03 11:30 EST

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

RNACCartesian Therapeutics2026-09-03 11:00 EST

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

View all latest news

X4 Pharmaceuticals

Rare Hematology Focus X4 Pharmaceuticals develops therapies for rare disorders in which dysregulated CXCR4 signaling contributes to abnormal retention of immune cells in bone marrow. Its lead molecule, mavorixafor, is an oral CXCR4 antagonist designed to mobilize neutrophils into circulation. Chronic Neutropenia Development Mavorixafor...

Recent company news

XFORX4 Pharmaceuticals2026-11-03 21:30 EST

X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026

XFORX4 Pharmaceuticals2026-10-09 11:00 EST

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

XFORX4 Pharmaceuticals2026-10-08 11:00 EST

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

XFORX4 Pharmaceuticals2026-10-01 20:30 EST

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

XFORX4 Pharmaceuticals2026-09-09 11:00 EST

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

Stock data

Close
3.07 USD
Market cap
381.05M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States